Schematic of the under-sink filter and POU UVC LED setup installed in each household. by Hania Zanib (21864477)

Subjects:

Paired influent and effluent concentrations of total coliforms (panel A), heterotrophic plate count (panel B), and male-specific coliphages (panel C) across POU UVC LED devices ins... by Hania Zanib (21864477)

Subjects:

Number of distinct colonies on HPC plates (representing diversity of heterotrophic bacteria) in paired influent and effluent samples. by Hania Zanib (21864477)

Subjects:

Vehicle fuel consumption and pollutant emissions at different penetration rate of CAVs. by Jianrong Cai (14245136)

Subjects:

The mixed traffic flow of CAV and HV in tunnel entrance zone. by Jianrong Cai (14245136)

Subjects:

Vehicle trajectory under different penetration rates of CAVs. by Jianrong Cai (14245136)

Subjects:

Examples of HPC plates from four different households showing variable removal depending on the microbial composition of the influent sample. by Hania Zanib (21864477)

Subjects:

Summary of POU UVC LED influent and effluent microbial water quality and log-removals. E. coli was not detected in any influent or effluent samples. Total coliform concentrations s... by Hania Zanib (21864477)

Subjects:

<i>Porphyromonas gingivalis</i> LPS pretreated by ozone ultrafine bubble water induces decreased TLR2 activation. by Mana Endo (22430706)

Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx by Tengxiang Zhao (20749475)

“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”

BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma. by Zahra Motahari (6814013)

Subjects:

The effect of MAGMAS inhibition on mitochondrial respiration and acidification rate in D425 cells. by Zahra Motahari (6814013)

Subjects:

PAM16 correlation with N-MYC. by Zahra Motahari (6814013)

Subjects:

MAGMAS inhibition on mitochondrial activity in medulloblastoma cells. by Zahra Motahari (6814013)

Subjects:

MAGMAS inhibition reduces DAOY cells migration. by Zahra Motahari (6814013)

Subjects:

MAGMAS inhibition induces medulloblastoma cell death. by Zahra Motahari (6814013)

Subjects:

BT9 reduces DAOY and D425 medulloblastoma cell invasion. by Zahra Motahari (6814013)

Subjects:

Expression of MAGMAS in medulloblastoma. by Zahra Motahari (6814013)

Subjects:

Bias risk assessments for each RCT study. by Xin Liu (43569)

Subjects: